Full-Time

Associate Director / Director

CMC, Chemistry, Manufacturing, And Controls

Confirmed live in the last 24 hours

Mammoth Biosciences

Mammoth Biosciences

51-200 employees

Develops CRISPR-based diagnostic tests for healthcare

Biotechnology
Healthcare

Compensation Overview

$163.5k - $220kAnnually

Senior, Expert

Mammoth Lakes, CA, USA

Position is onsite in Mammoth, Brisbane, CA.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Master’s Degree in a relevant scientific discipline
  • Prior experience with CMC development in Gene therapy is highly desired
  • Minimum of 10 years experience in biotech in large and small molecules (Director); minimum of 8 years experience (Associate Director)
  • Strong process understanding in one or some of: biologics, oligonucleotide, cell therapy, viral vectors, gene therapy or LNP
  • Experience in management of external CDMOs for DS/DP production
  • Strong understand of phase appropriate analytical development and manufacturing strategies for large and small molecules
  • Experience with US and EU CMC regulatory expectations, technical transfers, and complex development & manufacturing activities
  • Excellent people manager and cross-functional leader, able to lead diverse and complex teams with demonstrated success
  • Ability to travel both domestically and internationally, as needed
Responsibilities
  • Responsible for the design, development, phase appropriate qualification and verification/validation of the analytical methodologies for Mammoth’s pipeline
  • Identify opportunities to improve productivity and efficiency in projects and analytical science
  • Responsible for working as an integral part of diverse teams including CDMO analytical science teams
  • Lead the analytical science in project teams ensuring project alignment and fostering productive relationships with other core functions across the organization
  • Ensure data integrity and foster an environment of knowledge sharing throughout the medicine development lifecycle process
  • Ensure compliance with regulatory standards including GMP, ICH, EMA and FDA guidelines
  • Support the preparation of global regulatory submissions, scientific reports and patents
  • Develop phase‐appropriate quality control strategies for drug substance and drug product
  • Manage the drug substance and drug product stability study programs
  • Lead development of scientifically sound and data driven specifications
  • Oversee analytical and QC activities at CDMOs and Contracting Testing Laboratories, including the review and approval of test records, forms, methods, protocols and reports
  • Identification and development of suitable analytical methods to allow comprehensive characterization of both the quantitative and qualitative attributes of drug substance and drug product, associated impurities and excipients
  • Ensure documentation is maintained within the quality management system
  • Provide broad CMC support for internal programs from GLP tox through IND clinical programs
  • Ensure timely Drug Substance/Drug Product supply for non-clinical and clinical studies
  • Assist in the preparation and review of CMC sections of regulatory submissions, including IND, BLA, NDA, and MAA
  • Lead management of CMOs for process development and manufacturing of Drug Substances and Drug Products for toxicology and cGMP supplies
  • Develop and execute CMC strategies for early phase as well as late phase Drug Substance/Drug Product clinical supplies
  • Responsible for phase appropriate development and practical implementation of processes and controls for regulatory materials, intermediates, and drug substances and drug products
  • Coordinate with internal and external analytical/quality control, quality assurance, and regulatory team members to resolve technical issues or deviations during cGMP production
  • Create and manage contracts, requests for pricing, supply agreements, etc., related to drug substance and drug product manufacturing
  • Ensure activities are executed in alignment with established Quality Agreements. Author, review, and adjudicate relevant CMC sections for US and ex-US regulatory filings as needed
  • Work closely with cross functional teams to ensure seamless transitions between drug substance and drug product programs and suppliers
  • Develop and maintain collaborative relationships with internal stakeholders (e.g., Discovery, Non-Clinical, CMC, Clinical Operations, Regulatory, Quality, Finance, etc.) to deliver on internal goals and objectives

Mammoth Biosciences specializes in molecular diagnostics by utilizing CRISPR technology to create advanced diagnostic tests. These tests are designed to quickly and accurately identify health issues, including infectious diseases like COVID-19, right at the point of care. This allows patients to receive immediate results and consult with healthcare providers without the wait associated with traditional lab tests. The company primarily serves healthcare providers and research institutions, and it aims to provide rapid and reliable diagnostic solutions. What sets Mammoth Biosciences apart from its competitors is its CRISPR-based detection platform, which offers a wide range of testing possibilities for various applications. The company's goal is to enhance diagnostic capabilities and contribute to the scientific community through partnerships and educational initiatives.

Company Stage

N/A

Total Funding

$353.3M

Headquarters

Brisbane, California

Founded

2017

Growth & Insights
Headcount

6 month growth

4%

1 year growth

6%

2 year growth

-10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Mammoth's collaboration with Regeneron, including a $95M equity investment, underscores strong financial backing and potential for significant revenue through milestone payments and royalties.
  • The company's innovative ultracompact CRISPR systems show promise in developing one-time curative therapies, potentially revolutionizing treatment for genetic diseases.
  • Presentations at prestigious conferences like the American Society of Gene & Cell Therapy highlight Mammoth's leadership and influence in the scientific community.

What critics are saying

  • The recent layoffs indicate potential financial or strategic challenges, which could impact employee morale and job security.
  • The competitive landscape in CRISPR and gene-editing technologies is intense, requiring continuous innovation to maintain a leading position.

What makes Mammoth Biosciences unique

  • Mammoth Biosciences leverages proprietary ultracompact CRISPR technology, setting it apart from competitors in the molecular diagnostics and gene-editing space.
  • Their focus on rapid, point-of-need diagnostic tests provides immediate results, unlike traditional lab-based tests that require longer processing times.
  • Strategic partnerships with industry leaders like Regeneron enhance their capabilities and market reach, distinguishing them from other biotech firms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision

401(k)

Unlimited vacation

Transportation subsidy

Onsite amenities

Happy hours